METHODS: We included 64 vessels from 50 patients with chronic thromboembolic pulmonary hypertension who experienced hemoptysis during BPA in 2012-2023. Twenty-four vessels were treated conservatively (conservative group), while 40 were treated with GSE for persistent hemoptysis or desaturation despite conservative treatment (GSE group). We assessed hemoptysis-related parameters, perfusion of injured vessels pre- and post-treatment, and hemodynamic parameters through multiple BPA sessions.
RESULTS: Hemoptysis resolved immediately after the procedure in 67% of patients, including 70% of those in the GSE group, and all cases resolved by the next day. Of 37 embolized vessels, 41% showed spontaneous perfusion improvement in subsequent sessions. BPA was reperformed in 22 embolized vessels, with 86% showing further improvement, resulting in 70% of all embolized vessels finally showing improvement in perfusion. In both groups, clinical and hemodynamic parameters significantly improved after BPA.
CONCLUSIONS: Perfusion of embolized vessels improved after GSE, suggesting that GSE is safe for the treatment of severe persistent hemoptysis after conservative treatment.
方法:我们纳入了2012-2023年在BPA期间发生咯血的50例慢性血栓栓塞性肺动脉高压患者的64条血管。对24条血管进行保守治疗(保守组),尽管保守治疗,但仍有40人接受GSE治疗持续咯血或去饱和(GSE组)。我们评估了咯血相关参数,治疗前后损伤血管的灌注,和血液动力学参数通过多个BPA会话。
结果:67%的患者在手术后咯血立即消失,包括GSE组中70%的人,所有案件都在第二天解决。在37条栓塞血管中,41%的患者在随后的疗程中表现出自发灌注改善。在22条栓塞血管中重新进行了BPA,86%的人表现出进一步的改善,导致总共70%的栓塞血管最终显示灌注改善。在这两组中,BPA后临床和血流动力学参数明显改善。
结论:GSE后栓塞血管灌注改善,提示GSE对于保守治疗后严重持续性咯血的治疗是安全的。